Aligos Therapeutics Inc (ALGS)
0.818
-0.01
(-1.33%)
USD |
NASDAQ |
Apr 25, 16:00
0.8012
-0.02
(-2.05%)
After-Hours: 20:00
Aligos Therapeutics Total Assets (Quarterly): 151.53M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 151.53M |
| September 30, 2023 | 85.85M |
| June 30, 2023 | 106.13M |
| March 31, 2023 | 121.74M |
| December 31, 2022 | 146.69M |
| September 30, 2022 | 164.07M |
| June 30, 2022 | 182.52M |
| March 31, 2022 | 210.47M |
| Date | Value |
|---|---|
| December 31, 2021 | 235.37M |
| September 30, 2021 | 263.07M |
| June 30, 2021 | 211.88M |
| March 31, 2021 | 234.54M |
| December 31, 2020 | 265.30M |
| September 30, 2020 | 92.18M |
| June 30, 2020 | 148.68M |
| December 31, 2019 | 146.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
85.85M
Minimum
Sep 2023
265.30M
Maximum
Dec 2020
172.91M
Average
157.80M
Median
Total Assets (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 646.62M |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 59.45M |
| Shareholders Equity (Quarterly) | 92.08M |
| Current Ratio | 5.902 |